home.social

#dosage — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #dosage, aggregated by home.social.

  1. Ivermectin Dosage Guide for Humans (2026) In this Article : Overview of Ivermectin Dosage | Ivermectin Dosage for Adults | Ivermectin Dosage for Children | Ivermectin dosage restrictions | How to t...

    #anti-parasitic #dosage #ivermectin

    Origin | Interest | Match
  2. Break time and a tune I’m gonna dedicate to fucking shit birds Whiskey Pete Kegsbreath and the God damn, motherfucking FOTUS; what those assholes did to MG Gant as well as other women who have served in fucking combat with the rest of us is about as unfucking American as one can get. Or well on the way to it. Fuckers.
    #MusicOfMastodon
    #Dosage
    m.youtube.com/watch?v=v_0dQwib

  3. Best Ivermectin Dosage for Humans with Cancer or Different Cancer Types (2026) Introduction This article discusses dosage considerations and key factors regarding the use of ivermectin in cancer tr...

    #cancer #dosage #ivermectin #repurposed #drugs

    Origin | Interest | Match
  4. Best Fenbendazole Dosage for Humans: Safety, Side Effects and Efficacy Examined (2026) Fenbendazole is a broad spectrum anti-parasitic used against gastrointestinal parasites including: giardia, r...

    #benzimidazoles #cancer #dosage #fenbendazole #repurposed #drugs

    Origin | Interest | Match
  5. Best Fenbendazole Dosage for Humans: Safety, Side Effects and Efficacy Examined (2026) Fenbendazole is a broad spectrum anti-parasitic used against gastrointestinal parasites including: giardia, r...

    #benzimidazoles #cancer #dosage #fenbendazole #repurposed #drugs

    Origin | Interest | Match
  6. Best Fenbendazole Dosage for Humans: Safety, Side Effects and Efficacy Examined (2026) Fenbendazole is a broad spectrum anti-parasitic used against gastrointestinal parasites including: giardia, r...

    #benzimidazoles #cancer #dosage #fenbendazole #repurposed #drugs

    Origin | Interest | Match
  7. Best Fenbendazole Dosage for Humans: Safety, Side Effects and Efficacy Examined (2026) Fenbendazole is a broad spectrum anti-parasitic used against gastrointestinal parasites including: giardia, r...

    #benzimidazoles #cancer #dosage #fenbendazole #repurposed #drugs

    Origin | Interest | Match
  8. ✏️ Dosage is a program for managing treatment courses

    ©️ Free and open source program

    ⬇️ Install: Flatpak and Snap packages

    👉 linuxmasterclub.com/dosage/

    #Linux #Review #OpenSource #Software #Dosage

  9. ✏️ Dosage - программа для управления курсами лечения

    ©️ Бесплатная и с открытым исходным кодом программа

    ⬇️ Установка посредством: Flatpak и Snap пакетов

    👉 linuxmasterclub.ru/dosage/

    #Linux #OpenSource #Программа #Software #Dosage

  10. Yet another stunning sunset this evening on deck, the photo just not doing it justice as the sunlight is reflecting off leaves that have popped up on some of the smaller plants in a tree line.
    #MusicOfMastodon
    #90sAlbumRock
    #Dosage
    #NorthernWayOfLife
    m.youtube.com/watch?v=v_0dQwib

  11. The dangers of losing weight faster than your doctors can keep up - Enlarge (credit: Getty | Spauln)

    The dose makes the medicine—a... - arstechnica.com/?p=2041166 #hypothyroidism #trizepatide #science #obesity #thyroid #health #dosage #glp-1

  12. Soooo kickass to jam to whilst cruising through eastern Minnesota as the Wisconsin border nears.
    #MusicOfMastodon
    #ClassicRock
    #Dosage
    m.youtube.com/watch?v=v_0dQwib

  13. Another of those pretty evenings in the great nort’ woods of Wisconsin, heh, the “live” selection here on deck as I do my thing a favorite from Collective Soul.
    #MusicOfMastodon
    #ClassicRock
    #Dosage
    m.youtube.com/watch?v=kSvfoilx

  14. Periodic PSA:

    When taking acetaminophen, always take the max dose. I learned that from my chemo nurses. They were asking how much pain I was in, but they always brought me the max dose no matter what. I think there's a paper about it somewhere.

    Do keep in mind that it is not candy, however, and don't go over what the directions tell you you can take.

    Yep, I got a headache this morning, and I took the max dose.

    Tentacles, here I come! :madjoy:

    #PSA #acetaminophen #headache #dosage #chemo #cancer

  15. I've been having difficulties managing my #diabetes for some time, may be I should go see a doctor to see if they shouldn't change my prescription, I've been using the same medicine for about eleven years, may be, just may be the #dosage should be increased.

  16. Welp today I learned that in July, the black interior of the vehicle I drive gets hotter than the melting point of naproxen capsules.

    #mess #melted #dosage #impossible #to #determine

  17. Complicate this 🌍 you 🎁 for me
    I'm acquainted with your suffering
    Hold me up to all whom you've deceived
    Promises you break you still believe
    And all your weight
    It falls on me
    It brings me down
    And all your weight
    It falls on me
    It falls on me
    #Heavy
    #EdRoland
    #CollectiveSoul
    #Dosage 9 Feb 1999
    🐝🐝👄🐝🐝
    #progressive #rock #pop #1990s
    #movies #1970s
    youtu.be/spY8vWqNKF8

  18. @megmaker Many Brut Zeros are exactly that, but I remember this as a stand out in the Tarlant line-up at Temps des Copains, Nantes. #wine #Champagne #dosage

  19. Ever since the Human #Genome Project got rolling about thirty years ago (!) there’s been a lot of hope, and a lot of hype, about “#personalized #medicine” or “#precision medicine.” When it became clear that as always, the results weren’t going to match the hype, a lot of the hope went away too. This is a mistake.

    I’d like to talk about a quiet revolution in precision medicine: #genetic #dosage guidelines, a.k.a. #pharmacogenomic #labeling. The basic idea is that if you carry certain genetic #variants, you may need considerably more or less of a particular medication than the standard dose. Back in the ’90s, the kind of genetic #analysis needed to make use of that information was far too expensive and time-consuming for #clinical practice. These days you can get a complete #sequence in a matter of hours, for the same cost as a battery of standard blood tests.

    Fifteen years ago or so, the FDA approved the first pharmacogenomic labeling, for #warfarin. I was lucky enough to be in the room when the researchers made the announcement, and you could have heard a pin drop. Now it’s routine, and there’s a very long list: fda.gov/drugs/science-and-rese

    Everyone reacts to #medications differently. For most patients, most medications, and most diseases, there’s a fairly broad range of clinical effectiveness between “too little to do any good” and “way too much.” But for a substantial number of all of the above, the range is much narrower—and when you add up all the special cases, you get a hell of a lot of people!

    A lot of #drugs never get approved, despite showing promise in clinical #trials, because they only help a portion of the study population. Regulatory bodies like the #FDA are notoriously resistant to #subgroup analysis, and I get why: it’s very easy to cherry-pick those subjects in a clinical trial who happen to do well, and then come up with a post hoc explanation for why the test treatment worked for them but not for other participants. Some bad drugs have made it to market because of this kind of chicanery. But of course sometimes there’s a real reason one group does better, and as long as genetic testing is part of the study design from the start, it’s becoming possible to convince regulators that reason is valid.

    My work is mostly upstream of this, in the drug #target #discovery phase: finding disease-related #genes and #proteins that might be modifiable with the right medication. Since it’s part of the project from the start, that makes trial design easier, and the results more likely to be accepted. But I’d really like to see more #genomic analysis on drugs that aren’t designed that way too, and I think we’re getting there.

    Genetic dosage guidelines, though, are making a real difference in current practice. There are still considerable debates over the merits of many labelings, driven partly by legitimate #statistical concerns and partly by ideology. But the principle is proven beyond reasonable doubt, and it’s saving lives and relieving suffering right now, every day. Much more to come.

  20. Ever since the Human #Genome Project got rolling about thirty years ago (!) there’s been a lot of hope, and a lot of hype, about “#personalized #medicine” or “#precision medicine.” When it became clear that as always, the results weren’t going to match the hype, a lot of the hope went away too. This is a mistake.

    I’d like to talk about a quiet revolution in precision medicine: #genetic #dosage guidelines, a.k.a. #pharmacogenomic #labeling. The basic idea is that if you carry certain genetic #variants, you may need considerably more or less of a particular medication than the standard dose. Back in the ’90s, the kind of genetic #analysis needed to make use of that information was far too expensive and time-consuming for #clinical practice. These days you can get a complete #sequence in a matter of hours, for the same cost as a battery of standard blood tests.

    Fifteen years ago or so, the FDA approved the first pharmacogenomic labeling, for #warfarin. I was lucky enough to be in the room when the researchers made the announcement, and you could have heard a pin drop. Now it’s routine, and there’s a very long list: fda.gov/drugs/science-and-rese

    Everyone reacts to #medications differently. For most patients, most medications, and most diseases, there’s a fairly broad range of clinical effectiveness between “too little to do any good” and “way too much.” But for a substantial number of all of the above, the range is much narrower—and when you add up all the special cases, you get a hell of a lot of people!

    A lot of #drugs never get approved, despite showing promise in clinical #trials, because they only help a portion of the study population. Regulatory bodies like the #FDA are notoriously resistant to #subgroup analysis, and I get why: it’s very easy to cherry-pick those subjects in a clinical trial who happen to do well, and then come up with a post hoc explanation for why the test treatment worked for them but not for other participants. Some bad drugs have made it to market because of this kind of chicanery. But of course sometimes there’s a real reason one group does better, and as long as genetic testing is part of the study design from the start, it’s becoming possible to convince regulators that reason is valid.

    My work is mostly upstream of this, in the drug #target #discovery phase: finding disease-related #genes and #proteins that might be modifiable with the right medication. Since it’s part of the project from the start, that makes trial design easier, and the results more likely to be accepted. But I’d really like to see more #genomic analysis on drugs that aren’t designed that way too, and I think we’re getting there.

    Genetic dosage guidelines, though, are making a real difference in current practice. There are still considerable debates over the merits of many labelings, driven partly by legitimate #statistical concerns and partly by ideology. But the principle is proven beyond reasonable doubt, and it’s saving lives and relieving suffering right now, every day. Much more to come.

  21. Ever since the Human #Genome Project got rolling about thirty years ago (!) there’s been a lot of hope, and a lot of hype, about “#personalized #medicine” or “#precision medicine.” When it became clear that as always, the results weren’t going to match the hype, a lot of the hope went away too. This is a mistake.

    I’d like to talk about a quiet revolution in precision medicine: #genetic #dosage guidelines, a.k.a. #pharmacogenomic #labeling. The basic idea is that if you carry certain genetic #variants, you may need considerably more or less of a particular medication than the standard dose. Back in the ’90s, the kind of genetic #analysis needed to make use of that information was far too expensive and time-consuming for #clinical practice. These days you can get a complete #sequence in a matter of hours, for the same cost as a battery of standard blood tests.

    Fifteen years ago or so, the FDA approved the first pharmacogenomic labeling, for #warfarin. I was lucky enough to be in the room when the researchers made the announcement, and you could have heard a pin drop. Now it’s routine, and there’s a very long list: fda.gov/drugs/science-and-rese

    Everyone reacts to #medications differently. For most patients, most medications, and most diseases, there’s a fairly broad range of clinical effectiveness between “too little to do any good” and “way too much.” But for a substantial number of all of the above, the range is much narrower—and when you add up all the special cases, you get a hell of a lot of people!

    A lot of #drugs never get approved, despite showing promise in clinical #trials, because they only help a portion of the study population. Regulatory bodies like the #FDA are notoriously resistant to #subgroup analysis, and I get why: it’s very easy to cherry-pick those subjects in a clinical trial who happen to do well, and then come up with a post hoc explanation for why the test treatment worked for them but not for other participants. Some bad drugs have made it to market because of this kind of chicanery. But of course sometimes there’s a real reason one group does better, and as long as genetic testing is part of the study design from the start, it’s becoming possible to convince regulators that reason is valid.

    My work is mostly upstream of this, in the drug #target #discovery phase: finding disease-related #genes and #proteins that might be modifiable with the right medication. Since it’s part of the project from the start, that makes trial design easier, and the results more likely to be accepted. But I’d really like to see more #genomic analysis on drugs that aren’t designed that way too, and I think we’re getting there.

    Genetic dosage guidelines, though, are making a real difference in current practice. There are still considerable debates over the merits of many labelings, driven partly by legitimate #statistical concerns and partly by ideology. But the principle is proven beyond reasonable doubt, and it’s saving lives and relieving suffering right now, every day. Much more to come.